Patrick Machado

Insider Reports History

Entity
Individual
Location
201 Spear Street, 3 Rd Floor, San Francisco, CA
Signature
/s/ Sara Klein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Machado:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Director Common Stock 25.3K $444K $17.55 Jun 6, 2024 Direct
ACELYRIN, Inc. Director Common Stock 14.7K $109K $7.41 Oct 4, 2023 Indirect
ACELYRIN, Inc. Director Director Stock Option (right to buy) 92.2K Jun 7, 2024 Direct
CHIMERIX INC Director Stock Option (Right to Buy) 60K Jun 9, 2023 Direct
ALUMIS INC. Director Stock Option (Right to Buy) 38K Jul 1, 2024 Direct
Arcus Biosciences, Inc. Director Stock Option (Right to Buy) 24K Jun 6, 2024 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 15.5K Jun 5, 2024 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 3.3K Jun 17, 2024 Direct
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 17, 2022 Direct

Insider Reports Filed by Patrick Machado

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALMS ALUMIS INC. Jun 27, 2024 3 $0 4 Jul 1, 2024 Director
ALMS ALUMIS INC. Jun 27, 2024 0 $0 3 Jun 27, 2024 Director
ADVM Adverum Biotechnologies, Inc. Jun 17, 2024 2 $0 4 Jun 20, 2024 Director
SLRN ACELYRIN, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
RCUS Arcus Biosciences, Inc. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
XENE Xenon Pharmaceuticals Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
SLRN ACELYRIN, Inc. Oct 4, 2023 1 $0 4 Oct 6, 2023 Director
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director
RCUS Arcus Biosciences, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
ADVM Adverum Biotechnologies, Inc. Jun 9, 2023 2 $0 4 Jun 13, 2023 Director
CMRX CHIMERIX INC Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
XENE Xenon Pharmaceuticals Inc. Jun 2, 2023 1 $0 4 Jun 2, 2023 Director
SLRN ACELYRIN, Inc. May 9, 2023 8 $0 4 May 11, 2023 Director
SLRN ACELYRIN, Inc. May 4, 2023 1 $0 4 May 4, 2023 Director
SLRN ACELYRIN, Inc. May 4, 2023 0 $0 3 May 4, 2023 Director
TPTX Turning Point Therapeutics, Inc. Aug 17, 2022 3 $0 4 Aug 17, 2022 Director
XENE Xenon Pharmaceuticals Inc. Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
CMRX CHIMERIX INC Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
RCUS Arcus Biosciences, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
ADVM Adverum Biotechnologies, Inc. Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
ROIV Roivant Sciences Ltd. Oct 1, 2021 0 $0 3 Oct 1, 2021 Director
CMRX CHIMERIX INC Jun 23, 2021 1 $0 4 Jun 25, 2021 Director
RCUS Arcus Biosciences, Inc. Jun 3, 2021 2 $0 4 Jun 7, 2021 Director
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Director
TPTX Turning Point Therapeutics, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
ADVM Adverum Biotechnologies, Inc. May 12, 2021 2 $0 4 May 14, 2021 Director